← Back to Search

Local Anesthetic

Liposomal Bupivacaine TAP Block for Uterine Fibroids

Phase 3
Waitlist Available
Led By Jill H Tseng, MD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operative day 0 to day 8
Awards & highlights

Study Summary

This study is evaluating whether a specific type of surgery may help reduce pain and narcotic pain medications.

Eligible Conditions
  • Uterine Fibroids
  • Ovarian Cancer
  • Uterine Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operative day 0 to day 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-operative day 0 to day 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-operative opioid consumption
Secondary outcome measures
Ambulation
Bowel Function
Hospital stay
+4 more

Trial Design

3Treatment groups
Active Control
Group I: Liposomal Bupivacaine TAP BlockActive Control1 Intervention
After enrolling all 15 participants in the first arm, the next 15 patients enrolled will receive perioperative single-dose Liposomal Bupivacaine TAP blocks.
Group II: Bupivacaine TAP BlockActive Control1 Intervention
The first 15 patients enrolled will receive perioperative plain bupivacaine TAP blocks.
Group III: Liposomal Bupivacaine TAP Block with Re-dosingActive Control1 Intervention
After enrolling all 30 patients in the first two arms, the final 15 patients enrolled will receive perioperative Liposomal Bupivacaine TAP blocks followed by redosing of the TAP blocks in 48-60 hours.

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor
542 Previous Clinical Trials
1,921,956 Total Patients Enrolled
Jill H Tseng, MDPrincipal InvestigatorUniversity of California, Irvine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures
2019. "Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04849858.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top